| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 295.22B | 293.93B | 285.98B | 261.43B | 243.51B | 227.56B |
| Gross Profit | 78.77B | 77.93B | 79.49B | 81.28B | 76.29B | 71.07B |
| EBITDA | 24.93B | 28.24B | 33.07B | 28.11B | 24.42B | 21.46B |
| Net Income | 18.64B | 19.05B | 18.74B | 16.60B | 14.71B | 13.08B |
Balance Sheet | ||||||
| Total Assets | 299.57B | 295.92B | 290.11B | 253.38B | 235.84B | 217.46B |
| Cash, Cash Equivalents and Short-Term Investments | 55.48B | 59.67B | 56.82B | 56.97B | 54.66B | 48.64B |
| Total Debt | 71.55B | 66.52B | 27.93B | 32.69B | 32.35B | 26.18B |
| Total Liabilities | 165.23B | 168.45B | 171.72B | 147.47B | 141.13B | 136.38B |
| Stockholders Equity | 124.77B | 118.75B | 111.37B | 103.51B | 93.42B | 79.81B |
Cash Flow | ||||||
| Free Cash Flow | 16.87B | 17.33B | 16.47B | 15.36B | 11.95B | 15.76B |
| Operating Cash Flow | 26.03B | 25.95B | 26.54B | 25.26B | 20.15B | 23.13B |
| Investing Cash Flow | -15.60B | -17.25B | -20.07B | -17.09B | -8.92B | -8.07B |
| Financing Cash Flow | -14.02B | -17.21B | -7.91B | -7.84B | -3.82B | -15.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$36.80B | 5.77 | 17.96% | 5.70% | -6.76% | -10.28% | |
68 Neutral | HK$221.77B | 9.19 | 15.65% | 5.20% | 2.10% | -0.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | HK$5.82B | 6.06 | -4.81% | ― | 4.06% | -469.59% |